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The high-resolution proton magnetic resonance spectrum of leukaemic lymphoblasts is characteristic of neutral lipid in 
an isotropic environment. When such lymphoblasts are selected for resistance to the anticancer drug vinblastine, the in- 
tensity of this spectrum increases with increasing drug resistance. A reversal of this trend can be achieved by growing 
cells in delipidated serum, whereby lipid spectrum and drug resistance are diminished. However, both can be restored 
by subsequent regrowth in normal medium. Thus, although detectable genetic changes accompany the development of 
vinblastine resistance, the expression of these changes can be modulated by environmental lipid. 
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1. INTRODUCTION 
The development of cellular resistance to an- 
ticancer drug treatment is a major problem in 
cancer therapy which in some cases may be accom- 
panied by the development of cross-resistance to 
chemically unrelated compounds [1,2]. There is 
now ample evidence that multidrug resistance 
arises from the amplification of the mdrl gene, 
whose product is the plasma membrane P- 
glycoprotein which acts as an ATP-driven drug ef- 
flux pump [3-61. However, other changes such as 
enhanced mitochondrial function [7,8] and altera- 
tion to the plasma membrane lipid composition 
[9, lo] have been observed in multidrug-resistant 
cells. Furthermore, this type of multidrug 
resistance can be reversed in vitro by treatment 
with the calcium channel blocker verapamil 
[ 11,121, indicating that environmental factors can 
alter the expression of the cellular resistance. 
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We have previously established that high- 
resolution ‘H NMR signals obtained from cancer 
cells arise from neutral lipid in the plasma mem- 
branes. A new membrane model has been propos- 
ed to account for the physical and chemical 
characteristics of the plasma membrane of malig- 
nant cells [13]. 
These NMR signals have been used to assess the 
metastatic status of a rat mammary adenocar- 
cinema model [14]. We have also shown that the 
intensity of the lipid signal increases with increas- 
ing drug resistance [15]. 
How such lipid domains may be involved in drug 
resistance is unknown, although vinblastine treat- 
ment has been shown to cause accumulation of 
very low density lipoprotein (VLDL) secretory 
vesicles in hepatocytes [ 161. Our work has in- 
dicated that the drug itself interacts differently 
with the lipid domains in sensitive and resistant 
cells [ 151. Moreover, lipoproteins have been used 
to transport drugs such as adriamycin more effec- 
tively into cells [ 171. 
One method to test whether neutral lipid 
domains are important in drug resistance is to 
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study the effects of reducing their concentration in 
cells. The lipid content of cultured cells can be 
modified by changes in their growth medium, in 
particular by depletion of serum lipoproteins. 
Here, we have grown a human acute lymphoblastic 
leukaemic T cell line resistant to vinblastine in 
medium containing delipidated serum and shown a 
reduction in the neutral lipid content of the cells 
and a concomitant decrease in the level of 
vinblastine resistance. 
2. MATERIALS AND METHODS 
2.1. Cell lines and tissue cultures 
Cells of the acute lymphoblastic leukaemic T cell line CCRF- 
CEM, both sensitive and resistant to 5-10 ng/ml of vinblastine, 
were grown in RPMI-1640 medium supplemented with 10% 
foetal calf serum. The vinblastine-resistant cells were developed 
as reported [18]. The plasma membrane P-glycoprotein 
associated with vinblastine resistance is increased 3-fold in these 
cells [19]. All experiments were performed on cells which had 
been grown in drug-free medium for at least 2 weeks. 
Delipidated foetal calf serum was prepared by a cold ether ex- 
traction method (201. The protein was redissolved in a volume 
of water equivalent to the initial volume of serum and sterilized 
by filtration. Recovery of protein was quantitative but no lipid 
could be weighed on a Mettler MK60 balance after 
chloroform/methanol extraction of 5 ml serum. 
In the delipidated serum experiments vinblastine-resistant 
cells were grown in RPMI-1640 supplemented with 10% 
delipidated serum (delipidated medium). 
IGO measurements were made as in [ 181. The I& is defined 
as the concentration of drug that inhibits the 72 h growth of cell 
cultures by 50% when compared with the drug-free control 
cultures. Control cells doubled a minimum of twice during this 
period. 
2.2. Preparation of samples for NMR spectroscopy 
Cell samples were prepared for NMR experiments as de- 
scribed [15]. Cell viability was measured by dye exclusion 
before and after each experiment. Only those data obtained 
from cells with at least 90% viability were used. 
2.3. NMR spectroscopy 
‘H NMR spectra were recorded at 37°C using a Bruker 
AM 500 spectrometer. Peaks were referenced to aqueous 
sodium 3-(trimethyl-silyl)propanesulfonate. Two-dimensional 
correlated COSY spectra were recorded with a pulse sequence 
modified to compensate for rf inhomogeneity [21]. 
2.4. Lipid extraction 
Cells (10’) were pelleted at 700 x g for 10 min and washed 
three times with 45 ml physiological saline. The washed cells 
were resuspended in 2 ml of 10 mM Hepes (pH 7.2) and ex- 
tracted as described in [22]. 
Total protein, lipid, triglyceride, phospholipid and free and 
esterified cholesterol were measured on the whole-cell extracts 
1221. 
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3. RESULTS 
3.1. Cellular resistance 
The resistant cell line grown in the absence of 
vinblastine for 2 weeks prior to experimentation 
had an ICSO of 16 ng/ml. In contrast, the sensitive 
parent line had an ICSO of 3 ng/ml which was con- 
stant over a 3 l-day period. 
ICSO measurements (table 1) showed that the 
resistant cells became more sensitive to drug treat- 
ment during the 13 days of growth in delipidated 
medium. Although the IGO varied between 10 and 
12 ng/ml over the following 2 weeks of culture, 
there was an overall 38% mean loss of resistance. 
Cell doubling times during culture in delipidated 
medium were variable (21-37 h). However, we 
conclude from the data that the ICSO is indepen- 
dent of growth rate. 
When cells were returned to full medium, drug 
resistance was regained after 2 weeks in culture, 
without added vinblastine. 
3.2. ‘H NA4R spectroscopy 
The ‘H NMR spectra of the vinblastine-sensitive 
and -resistant CCRF-CEM cell lines are shown in 
fig. 1A and B, respectively. As reported previously 
[15] the intensity of the lipid resonances increases 
with drug resistance. The COSY spectrum of resis- 
tant cells is shown in fig.2A. Assignments of lipid 
resonances are as in structure 1 and have been 
previously reported [21]. Cross-peaks Y and Y’ 
have been assigned to fucosylated species on the 
plasma membrane [141. 
The NMR spectrum of the resistant cell line 
changed dramatically after the cells were cultured 
in delipidated medium for 13 days (fig.lC). The 
Table 1 
Effect of growing vinblastine-resistant leukaemic lymphoblasts 
in delipidated medium 
Days of Doubling IC_VJ (ng vin- Loss of 
growth time (h) blastine per ml) resistance (%) 
0 22 16 
13 37 10 (16) 39 
25 35 12 (19) 37 
31 23 10 (16) 38 
The ICso is based on the 72 h growth of cell cultures as 
described in section 2. The ICSO of cells in full growth medium 
is given in parentheses 
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Fig.1. One-dimensional ‘H NMR spectra of: (A) CCRF-CEM 
cells (1 x 108) sensitive to vinblastine; (B) CCRF-CEM cells 
resistant o 10 n&ml of vinblastine; (C) resistant cells grown in 
delipidated serum; (D) as for (C) but regrown in full medium. 
Spectra were recorded at 37°C with the sample spinning. Cells 
were suspended in PBS/D20 and the residual HOD peak was 
suppressed by gated irradiation. 
one-dimensional NMR spectrum was poorly 
resolved with a significant decrease in the intensity 
of the acyl chain resonances at 1.3 ppm (-CHz-). 
This indicates a major reduction in the amount of 
isotropically tumbling neutral lipid. 
The broadening of these signals is confirmed in 
the COSY spectra (fig.2B). None of the cross- 
peaks associated with triglyceride is apparent 
although cross-peaks arising from cellular 
metabolites are still present, 
When the cells were grown again in full medium, 
they regained their high-resolution lipid signal 
(fig.lD) as well as their drug resistance. 
3.3. Lipid composition 
Total lipid, protein, free and esterified 
cholesterol, triglyceride and phospholipid levels in 
r 
6 5 4 PPZ 2 1 0 
r; B 
r 0 
1 
2 
4 
5 
6 
0 
1 
2 
E 
3: 
4 
5 
6 
r t 
6 5 4 PPrr” 2 1 0 
Fig.2. Two-dimensional symmetrised COSY spectra of: (A) 
CCRF-CEM cells (1 x 108) resistant o vinblastine; (B) resistant 
cells grown in delipidated serum. Sinebell and Gaussian (LB = 
- 30, GB = 0.25) window function were applied in the t1 and 
fz domains, respectively. Lipid acyl chain assignments are 
indicated according to structure 1. Cross-peaks Y and Y’ have 
been assigned to fucose and lactate, respectively. 
resistant cell lines cultured in normal and 
delipidated medium are listed in table 2. 
After culture of the resistant cell line in 
delipidated medium for 28 days, all four classes of 
lipids assayed were diminished 2-3-fold although 
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Table 2 
Whole-cell lipid and protein composition of vinblastine- 
resistant cells grown in normal and delipidated medium 
Normal serum Delipidated serum 
Free cholesterol 245 + 18 129 * 54 
Cholesterol ester 51 t9 22 + 19 
Triglyceride IQ k 4 39 II 15 
Phospholipid 1035 f 12 456 + 121 
Total lipid 1.37 + 0.14 1.49 + 0.80 
Total protein 1.8 f 0.1 2.20 f 0.6 
Data are expressed as nmol per lo8 cells for the four lipid classes 
and the values represent the mean + SD determined from 
duplicate assays on three different extractions. The total lipid 
and protein content are expressed as mg per lo8 cells 
total protein and lipid levels were maintained. Not 
all the lipid can be accounted for in the delipidated 
cells, but the neutral lipids which give rise to the 
NMR signal are clearly reduced. The 
cholesterol :phospholipid ratio was maintained at 
0.25 + 0.01 in cells whether grown in normal or 
delipidated media. The triglyceride :phospholipid 
and triglyceride :cholesterol ester ratios were also 
maintained when the resistant cells were grown in 
delipidated medium despite the decrease in each of 
the four lipid classes. 
We have previously shown that cells resistant o 
higher levels of vinblastine (20 ng/ml) have an in- 
creased total lipid and protein content [23]. The 
lipid data presented here are in agreement with this 
latter observation, since the resistant cells which 
became more drug sensitive following growth in 
delipidated medium also incurred a net loss of the 
four classes of lipid assayed. 
4. CONCLUSIONS 
Growth of leukaemic T cells in delipidated 
medium caused the high-resolution NMR spectra, 
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indicative of isotropically tumbling lipid domains, 
to diminish. These neutral lipid domains have a 
lipid content which is largely triglyceride, and thus 
the NMR spectra indicate a decrease in cellular 
triglyceride or a change in the lipid’s physical en- 
vironment. These changes were accompanied by a 
40% increase in sensitivity to vinblastine. 
This effect, however, is reversible and after 
regrowth in full medium, the cells regained both 
their high-resolution NMR lipid signal and drug 
resistance. 
It is clear that genetic factors, in particular 
amplification of the gene that codes for the P- 
glycoprotein, play a major role in cellular drug 
resistance [6]. However, the present data indicate 
that environmental conditions, in particular lipids 
in the medium, can modulate low levels of cellular 
resistance to vinblastine. We postulate that the 
NMR-sensitive lipid domains within the plasma 
membrane dissolve lipophilic drugs and thereby 
reduce their cellular toxicity. In the absence of 
serum lipid, cellular metabolism is altered such 
that these lipid domains are diminished or changed 
in structure and are no longer effective reservoirs 
for drugs. The documented changes in plasma 
membrane, cytoskeleton and mitochondria may be 
associated with the effectiveness of the transport 
of these lipid domains, and hence drug, out of the 
cells. 
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